Standard Biotools (LAB) Gross Profit Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 132.13 Bn | 129.26 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 111.43 Bn | 102.21 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 68.97 Bn | 67.52 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.64 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.91 Bn | 27.79 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 28.86 Bn | 26.58 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 28.12 Bn | 27.54 Bn | - | - |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | 0.21% |
| 10 | Standard Biotools | 302.22 Mn | -152.96 Mn | 11.31 Mn | -2.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.71% |
| Dec 31, 2025 | 0.64% |
| Sep 30, 2025 | 0.95% |
| Jun 30, 2025 | 33.90% |
| Mar 31, 2025 | -23.39% |
| Sep 30, 2024 | -39.44% |
| Jun 30, 2024 | -44.25% |
| Mar 31, 2024 | 4.61% |
| Dec 31, 2023 | -31.66% |
| Sep 30, 2023 | -18.76% |
| Jun 30, 2023 | 4.78% |
| Mar 31, 2023 | -1.88% |
| Dec 31, 2022 | -14.53% |
| Sep 30, 2022 | -12.66% |
| Jun 30, 2022 | -33.95% |
| Mar 31, 2022 | 13.09% |
| Sep 30, 2021 | 51.11% |
| Jun 30, 2021 | 63.93% |
| Mar 31, 2021 | 16.32% |
| Dec 31, 2020 | 61.72% |